Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The European Commission (EC) has approved Novartis’ Rhapsido (remibrutinib) for ...
Organon, created through a spinoff from Merck & Co (MSD) in 2021, distributes mo...
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmo...
Five-year agreement focuses on open science access, joint research and capabili...
Former Cipla CEO to lead next phase for CDMO platform focused on complex chemis...
The inaugural edition of FDD Conclave - Mumbai Connect, a city-focused platform...
Approval for 0.5 mg capsules therapeutically equivalent to Novartis’ Gilenya; m...
Deal combines portfolios and expands presence across women’s health, biosimilar...
Under the agreement, Apotex will acquire Cumberland’s branded medicines for cash...
The initiative aims to link external scientific data with internal R&D planning ...
Agreements focus on medicine quality testing, pharmacovigilance, and pharmaceut...
Company outlines expansion across multiple states and pipeline of formulations ...
The approval expands the previous indication from those aged eight and above and...
Platform to support workforce development for quality, production and regulator...
Transaction to create integrated global biosimilars platform combining developm...
The collaboration aims to implement an agentic platform across MSD’s research an...